Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model

R. Ali, R. A. Naqvi, S. Kumar, Ajaz Ahmad Bhat, D. N. Rao

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Yersinia pestis is a facultative bacterium that can survive and proliferate inside host macrophages and cause bubonic, pneumonic and systemic infection. Apart from humoral response, cell-mediated protection plays a major role in combating the disease. Fraction 1 capsular antigen (F1-Ag) of Y. pestis has long been exploited as a vaccine candidate. In this study, F1-multiple antigenic peptide (F1-MAP or MAP)-specific cell-mediated and cytokine responses were studied in murine model. MAP consisting of three B and one T cell epitopes of F1-antigen with one palmitoyl residue was synthesized using Fmoc chemistry. Mice were immunized with different formulations of MAP in poly DL-lactide-co-glycolide (PLGA) microspheres. F1-MAP with CpG oligodeoxynucleotide (CpG-ODN) as an adjuvant showed enhanced in vitro T cell proliferation and Th1 (IL-2, IFN-γ and TNF-α) and Th17 (IL-17A) cytokine secretion. Similar formulation also showed significantly higher numbers of cytokine (IL-2, IFN-γ)-secreting cells. Moreover, F1-MAP with CpG formulation showed significantly high (P < 0.001) percentage of CD4+ IFN-γ+ cells as compared to CD8+ IFN-γ+ cells, and also more (CD4- IFN-γ)+ cells secrete perforin and granzyme as compared to (CD8- IFN-γ)+ showing Th1 response. Thus, the study highlights the importance of Th1 cytokine and existence of CD4+ and CD8+ immune response. This study proposes a new perspective for the development of vaccination strategies for Y. pestis that trigger T cell immune response.

Original languageEnglish
Pages (from-to)361-371
Number of pages11
JournalScandinavian Journal of Immunology
Volume77
Issue number5
DOIs
Publication statusPublished - 1 May 2013
Externally publishedYes

Fingerprint

Peptide T
B-Lymphocyte Epitopes
T-Lymphocyte Epitopes
Yersinia pestis
Antigens
Cytokines
Interleukin-2
T-Lymphocytes
Polyglactin 910
Granzymes
Perforin
Cytoprotection
Interleukin-17
Oligodeoxyribonucleotides
Microspheres
Vaccination
Vaccines
Macrophages
Cell Proliferation
peptide B

ASJC Scopus subject areas

  • Immunology

Cite this

Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model. / Ali, R.; Naqvi, R. A.; Kumar, S.; Bhat, Ajaz Ahmad; Rao, D. N.

In: Scandinavian Journal of Immunology, Vol. 77, No. 5, 01.05.2013, p. 361-371.

Research output: Contribution to journalArticle

@article{ef66eca019f040d19f907376c6fbaf2c,
title = "Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model",
abstract = "Yersinia pestis is a facultative bacterium that can survive and proliferate inside host macrophages and cause bubonic, pneumonic and systemic infection. Apart from humoral response, cell-mediated protection plays a major role in combating the disease. Fraction 1 capsular antigen (F1-Ag) of Y. pestis has long been exploited as a vaccine candidate. In this study, F1-multiple antigenic peptide (F1-MAP or MAP)-specific cell-mediated and cytokine responses were studied in murine model. MAP consisting of three B and one T cell epitopes of F1-antigen with one palmitoyl residue was synthesized using Fmoc chemistry. Mice were immunized with different formulations of MAP in poly DL-lactide-co-glycolide (PLGA) microspheres. F1-MAP with CpG oligodeoxynucleotide (CpG-ODN) as an adjuvant showed enhanced in vitro T cell proliferation and Th1 (IL-2, IFN-γ and TNF-α) and Th17 (IL-17A) cytokine secretion. Similar formulation also showed significantly higher numbers of cytokine (IL-2, IFN-γ)-secreting cells. Moreover, F1-MAP with CpG formulation showed significantly high (P < 0.001) percentage of CD4+ IFN-γ+ cells as compared to CD8+ IFN-γ+ cells, and also more (CD4- IFN-γ)+ cells secrete perforin and granzyme as compared to (CD8- IFN-γ)+ showing Th1 response. Thus, the study highlights the importance of Th1 cytokine and existence of CD4+ and CD8+ immune response. This study proposes a new perspective for the development of vaccination strategies for Y. pestis that trigger T cell immune response.",
author = "R. Ali and Naqvi, {R. A.} and S. Kumar and Bhat, {Ajaz Ahmad} and Rao, {D. N.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1111/sji.12042",
language = "English",
volume = "77",
pages = "361--371",
journal = "Scandinavian Journal of Immunology",
issn = "0300-9475",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model

AU - Ali, R.

AU - Naqvi, R. A.

AU - Kumar, S.

AU - Bhat, Ajaz Ahmad

AU - Rao, D. N.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Yersinia pestis is a facultative bacterium that can survive and proliferate inside host macrophages and cause bubonic, pneumonic and systemic infection. Apart from humoral response, cell-mediated protection plays a major role in combating the disease. Fraction 1 capsular antigen (F1-Ag) of Y. pestis has long been exploited as a vaccine candidate. In this study, F1-multiple antigenic peptide (F1-MAP or MAP)-specific cell-mediated and cytokine responses were studied in murine model. MAP consisting of three B and one T cell epitopes of F1-antigen with one palmitoyl residue was synthesized using Fmoc chemistry. Mice were immunized with different formulations of MAP in poly DL-lactide-co-glycolide (PLGA) microspheres. F1-MAP with CpG oligodeoxynucleotide (CpG-ODN) as an adjuvant showed enhanced in vitro T cell proliferation and Th1 (IL-2, IFN-γ and TNF-α) and Th17 (IL-17A) cytokine secretion. Similar formulation also showed significantly higher numbers of cytokine (IL-2, IFN-γ)-secreting cells. Moreover, F1-MAP with CpG formulation showed significantly high (P < 0.001) percentage of CD4+ IFN-γ+ cells as compared to CD8+ IFN-γ+ cells, and also more (CD4- IFN-γ)+ cells secrete perforin and granzyme as compared to (CD8- IFN-γ)+ showing Th1 response. Thus, the study highlights the importance of Th1 cytokine and existence of CD4+ and CD8+ immune response. This study proposes a new perspective for the development of vaccination strategies for Y. pestis that trigger T cell immune response.

AB - Yersinia pestis is a facultative bacterium that can survive and proliferate inside host macrophages and cause bubonic, pneumonic and systemic infection. Apart from humoral response, cell-mediated protection plays a major role in combating the disease. Fraction 1 capsular antigen (F1-Ag) of Y. pestis has long been exploited as a vaccine candidate. In this study, F1-multiple antigenic peptide (F1-MAP or MAP)-specific cell-mediated and cytokine responses were studied in murine model. MAP consisting of three B and one T cell epitopes of F1-antigen with one palmitoyl residue was synthesized using Fmoc chemistry. Mice were immunized with different formulations of MAP in poly DL-lactide-co-glycolide (PLGA) microspheres. F1-MAP with CpG oligodeoxynucleotide (CpG-ODN) as an adjuvant showed enhanced in vitro T cell proliferation and Th1 (IL-2, IFN-γ and TNF-α) and Th17 (IL-17A) cytokine secretion. Similar formulation also showed significantly higher numbers of cytokine (IL-2, IFN-γ)-secreting cells. Moreover, F1-MAP with CpG formulation showed significantly high (P < 0.001) percentage of CD4+ IFN-γ+ cells as compared to CD8+ IFN-γ+ cells, and also more (CD4- IFN-γ)+ cells secrete perforin and granzyme as compared to (CD8- IFN-γ)+ showing Th1 response. Thus, the study highlights the importance of Th1 cytokine and existence of CD4+ and CD8+ immune response. This study proposes a new perspective for the development of vaccination strategies for Y. pestis that trigger T cell immune response.

UR - http://www.scopus.com/inward/record.url?scp=84876792470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876792470&partnerID=8YFLogxK

U2 - 10.1111/sji.12042

DO - 10.1111/sji.12042

M3 - Article

VL - 77

SP - 361

EP - 371

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

SN - 0300-9475

IS - 5

ER -